FDA
-
-
-
-
-
-
-
CDT Announces Canadian Patent for AZD5904 in Male Infertility
-
-
-
-
-
-
-
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
-
-
-
-
-
-
-
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
-
-
-
-
-
-
-
CDT acquires 20% stake in Sarborg for $115 million
-
-
-
-
-
-
-
CDT Equity purchases 9.26 bitcoin for $1 million
-
-
-
-
-
-
-
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
-
-
-
-
-
-
-
Conduit Pharmaceuticals (CDT) Announces 1:100 Reverse Share Split
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

